AnGes, Inc. (TYO:4563)
91.00
0.00 (0.00%)
Sep 12, 2025, 3:30 PM JST
AnGes Revenue
AnGes had revenue of 245.00M JPY in the quarter ending June 30, 2025, with 4.70% growth. This brings the company's revenue in the last twelve months to 710.00M, up 58.48% year-over-year. In the year 2024, AnGes had annual revenue of 643.00M with 323.03% growth.
Revenue (ttm)
710.00M
Revenue Growth
+58.48%
P/S Ratio
46.44
Revenue / Employee
12.91M
Employees
55
Market Cap
32.97B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 643.00M | 491.00M | 323.03% |
Dec 31, 2023 | 152.00M | 85.00M | 126.87% |
Dec 31, 2022 | 67.00M | 3.00M | 4.69% |
Dec 31, 2021 | 64.00M | 25.00M | 64.10% |
Dec 31, 2020 | 39.00M | -287.00M | -88.04% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,196.21B |
HOYA Corporation | 876.09B |
Takeda Pharmaceutical Company | 4,480.25B |
Daiichi Sankyo Company | 1,924.68B |
Otsuka Holdings | 2,401.70B |
Terumo | 1,037.94B |
Astellas Pharma | 1,944.99B |
Shionogi & | 440.50B |